Overview

PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP

Status:
Completed
Trial end date:
2013-01-22
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to measure brain CB1 receptors in the hope to better understand how they work, so that one day we can understand how the CB1 receptors are involved in psychiatric, neurological, and behavioral disorders.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)